Palomar to Unveil New Laser-Assisted Liposuction Platform at the American Society for Laser Medicine & Surgery

Saturday, March 29, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

BURLINGTON, Mass., March 28 Palomar MedicalTechnologies Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, announced today that it will unveil itslatest innovation in aesthetic laser technology at the 28th annual conferenceof the American Society for Laser Medicine & Surgery (ASLMS) in KissimmeeFlorida, April 2-6. Palomar will display a new platform called the Aspire(TM)aesthetic laser platform and Stylus(TM) Sculpter laser-assisted liposuctionhandpiece in booth #507 in the ASLMS exhibit hall. The Aspire platform willallow Palomar to offer solutions to new procedures which are in high-demandincluding laser-assisted liposuction. The Aspire platform will complement thebroad range of aesthetic applications offered by Palomar's flagship StarLux(R)500 laser and pulsed-light platform.

Traditional liposuction is one of the most commonly performed plasticsurgery procedures, according to the 2007 survey from the American Society ofAesthetic Plastic Surgery. Laser-assisted liposuction holds out the promisefor a better technique due to the laser's ability to quickly and selectivelymelt fat and heat surrounding tissue. Palomar's approach to laser-assistedliposuction with the Aspire platform and Stylus Sculpter handpiece is toutilize unique tip designs and selective and efficient wavelengths for meltingfat and providing the desired thermal effects on surrounding tissue.

Chief Executive Officer Joseph P. Caruso commented, "The unveiling of theAspire platform and Stylus Sculpter handpiece is the culmination of years ofresearch directed to absorption of light by fat. Our system uses optimalwavelengths to melt fat and provide the appropriate amount of heat to thesurrounding tissue. As with all Palomar products, the Aspire platform is basedon sound scientific principles developed and tested by Palomar's research anddevelopment organization, which is preeminent in the light-based aestheticindustry."

Mr. Caruso continued, "The Aspire platform is an ideal complement to theStarLux platform for providing opportunities for even more treatmentmodalities. With the new aesthetic procedures that will be possible withAspire, and the many popular treatments, including hair removal, skinrejuvenation and skin resurfacing, available with the StarLux(R) 500,practitioners will be able to offer a complete suite of the most-requestedaesthetic procedures."

The Aspire Platform and Stylus Sculpter liposuction laser-assistedhandpiece are pending FDA clearance and should be available for shipment inthe third quarter.

In addition to the introduction of the Aspire platform, the followingpresentations at ASLMS are relevant to Palomar technology:

About Palomar Medical Technologies Inc.: Palomar is a leading researcherand developer of light-based systems for cosmetic treatments. Palomarpioneered the optical hair removal field, when, in 1997, it introduced thefirst high-powered laser hair removal system. Since then, many of the majoradvances in light-based hair removal have been based on Palomar technology. InDecember 2006, Palomar became the first company to receive a 510(k) over-the-counter (OTC) clearance from the United States Food and Drug Administration(FDA) for a new, patented, home use, light-based hair removal device. OTCclearance allows the product to be marketed and sold directly to consumerswithout a prescription. There are now millions of light-based cosmeticprocedures performed around the world every year in physician offices,clinics, spas and salons. Palomar is testing many new and excitingapplications to further advance the hair removal market and other cosmeticapplications. Palomar is focused on developing proprietary light-basedtechnology for introduction to the mass markets. Palomar has granted TheProcter & Gamble Company a non-exclusive License Agreement to certain patents,technology and FDA

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store